Fortress Biotech Q3 EPS $(0.23) Misses $(0.15) Estimate, Sales $19.159M Miss $21.575M Estimate
Benzinga Newsdesk 15 hours ago
NewsEarningsEarnings Misses
Fortress Biotech (NASDAQ:FBIO) reported quarterly losses of $(0.23) per share which missed the analyst consensus estimate of $(0.15) by 53.33 percent. This is a 309.09 percent decrease over earnings of $0.11 per share
Fortress Biotech (NASDAQ:FBIO) reported quarterly losses of $(0.23) per share which missed the analyst consensus estimate of $(0.15) by 53.33 percent. This is a 309.09 percent decrease over earnings of $0.11 per share from the same period last year. The company reported quarterly sales of $19.159 million which missed the analyst consensus estimate of $21.575 million by 11.20 percent. This is a 8.67 percent increase over sales of $17.631 million the same period last year.